Tab Cipro
Ciprofloxacin tablet pharmacology indications dosage
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 4687
Ciprofloxacin side effects contraindications drug interactions
Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Page 163
| Form | Strengths |
|---|---|
| Immediate-release tablet | 250 mg, 500 mg, 750 mg |
| Extended-release tablet (Cipro XR) | 500 mg, 1000 mg |
| Infection | Dose | Frequency | Duration |
|---|---|---|---|
| Uncomplicated UTI | 250 mg | Every 12 h | 3 days |
| Complicated UTI / Pyelonephritis | 500 mg | Every 12 h | 7–14 days |
| Respiratory tract infections | 500–750 mg | Every 12 h | 7–14 days |
| Skin & soft tissue infections | 500–750 mg | Every 12 h | 7–14 days |
| Bone & joint infections | 500–750 mg | Every 12 h | 4–8 weeks |
| Infectious diarrhea / Traveler's diarrhea | 500 mg | Every 12 h | 1–5 days |
| Typhoid fever | 500 mg | Every 12 h | 10 days |
| Gonorrhea (uncomplicated) | 500 mg | Single dose | — |
| Inhalation anthrax (post-exposure) | 500 mg | Every 12 h | 60 days |
| Aeromonas infections | 500 mg | Every 12 h | Per response |
| IV equivalent | 400 mg | Every 12 h | — |
| Parameter | Value |
|---|---|
| Bioavailability (oral) | ~70–80% |
| Half-life | ~4–6 hours |
| Protein binding | ~20–40% |
| Route of elimination | Renal (primary) + hepatic |
| Dose adjustment needed | Yes, if CrCl < 30 mL/min |
| Effect | Details |
|---|---|
| Tendonitis / Tendon rupture | Especially Achilles; risk higher in elderly, corticosteroid users |
| QT prolongation | Avoid with other QT-prolonging drugs |
| Peripheral neuropathy | May be irreversible |
| CNS effects | Seizures, confusion, tremors |
| C. difficile colitis | Risk with any antibiotic |
| Photosensitivity | Avoid prolonged sun exposure |
| Hypoglycemia/hyperglycemia | Especially in diabetics on hypoglycemics |
⚠️ Black Box Warning (FDA): Tendinitis and tendon rupture; peripheral neuropathy; CNS effects; exacerbation of myasthenia gravis.
| Drug/Group | Interaction |
|---|---|
| Antacids (Al/Mg), Sucralfate, Iron, Zinc | Reduce ciprofloxacin absorption — take 2 h before or 6 h after |
| Theophylline | Elevated theophylline levels → toxicity |
| Warfarin | Increased anticoagulant effect (monitor INR) |
| NSAIDs | Increased CNS stimulation/seizure risk |
| QT-prolonging drugs | Additive QT prolongation |
| Tizanidine | Contraindicated — severe hypotension |
| Metformin | May increase metformin exposure |